These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2982530)

  • 1. Mechanisms of abnormalities in host defences against bacterial infection in liver disease.
    Rajkovic IA; Williams R
    Clin Sci (Lond); 1985 Mar; 68(3):247-53. PubMed ID: 2982530
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired ability of neutrophils to produce oxygen-derived free radicals in patients with chronic liver disease and hepatocellular carcinoma.
    Uehara M; Sato N
    Hepatology; 1994 Aug; 20(2):326-30. PubMed ID: 8045492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assay of the carcinoembryonic antigen (CEA) in acute and chronic liver diseases and hepatocellular carcinoma].
    Piantino P; Gallo V; Pecchio F; Garlanda PF; Bonardi O
    Minerva Med; 1981 Apr; 72(17):1059-64. PubMed ID: 6262678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired opsonization by serum from patients with chronic liver disease.
    Wyke RJ; Rajkovic IA; Williams R
    Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects in serum attractant activity in different types of chronic liver disease.
    Yousif-Kadaru AG; Rajkovic IA; Wyke RJ; Williams R
    Gut; 1984 Jan; 25(1):79-84. PubMed ID: 6690377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil phagocytic and bactericidal function in primary biliary cirrhosis and other chronic liver diseases.
    De Fernandez MA; Clark A; Triger DR
    Clin Exp Immunol; 1987 Mar; 67(3):655-61. PubMed ID: 3608234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of Vibrio vulnificus in whole blood from patients with chronic liver diseases: association with phagocytosis by neutrophils and serum ferritin levels.
    Hor LI; Chang TT; Wang ST
    J Infect Dis; 1999 Jan; 179(1):275-8. PubMed ID: 9841854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional evaluation in liver disease: immunologic function.
    Mackay IR
    Lab Res Methods Biol Med; 1983; 7():89-101. PubMed ID: 6353116
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of a microsomal antigen and its antibody in human liver diseases.
    Penner E; Emejuaiwe SO; Milgrom F
    Int Arch Allergy Appl Immunol; 1979; 59(4):459-64. PubMed ID: 221426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total haemolytic complement activity in apparently healthy Pakistanis and patients with liver disease.
    Siddiqui M; Zuberi SJ
    J Pak Med Assoc; 1978 Jun; 28(6):67-8. PubMed ID: 99528
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocytes in liver diseases.
    Paronetto F; Colucci G; Colombo M
    Prog Liver Dis; 1986; 8():191-208. PubMed ID: 3520659
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmunity and liver diseases.
    Vento S; Eddleston A
    Prog Liver Dis; 1990; 9():335-43. PubMed ID: 2156300
    [No Abstract]   [Full Text] [Related]  

  • 13. [HBS antigen and liver diseases].
    Blüger A; Kartaschowa O; Zalcmane V; Saldava L
    Dtsch Z Verdau Stoffwechselkr; 1983; 43(2):56-64. PubMed ID: 6307637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.
    Bruix J; Barrera JM; Calvet X; Ercilla G; Costa J; Sanchez-Tapias JM; Ventura M; Vall M; Bruguera M; Bru C
    Lancet; 1989 Oct; 2(8670):1004-6. PubMed ID: 2572739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical Implications of Inflammation and Immunity in Acute and Chronic Liver Disease: Advances in Diagnosis, Treatment and Clinical Practice. AASLD Liver Meeting, Boston, November 7-11, 2014].
    Pár A
    Orv Hetil; 2015 May; 156(21):869-72. PubMed ID: 26038995
    [No Abstract]   [Full Text] [Related]  

  • 16. Neutrophil adherence in chronic liver disease and fulminant hepatic failure.
    Altin M; Rajkovic IA; Hughes RD; Williams R
    Gut; 1983 Aug; 24(8):746-50. PubMed ID: 6873736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonparticipation of C1q in the decrease of complement activity in the cold in sera of patients with chronic liver diseases.
    Yoshida H; Morito T; Onizawa N; Kasukawa R
    Int Arch Allergy Appl Immunol; 1980; 62(4):433-41. PubMed ID: 6247290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relation of hepatitis B virus to chronic hepatitis, cirrhosis and primary hepatocellar carcinoma--a study of 367 cases of liver biopsy with orcein staining].
    Tang YH
    Zhonghua Nei Ke Za Zhi; 1983 Jan; 22(1):17-20, 62-3. PubMed ID: 6188585
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphocyte responsiveness per unit volume of blood in patients with chronic nonalcoholic and alcoholic liver disease. Plasma inhibitory factors and functional defects of responder cells.
    Behrens U; Friedrich I; Vernace S; Schaffner F; Paronetto F
    J Clin Lab Immunol; 1982 Sep; 8(3):143-52. PubMed ID: 6982341
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain.
    Reed WD; Stern RB; Eddleston AL; Williams R; Zuckerman AJ; Bowes A; Earl PM
    Lancet; 1973 Sep; 2(7831):690-4. PubMed ID: 4125788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.